As the holidays approach, questions about maintaining nutrition, wellness, and a healthy lifestyle take center stage. Australian nutrition icons Kim Morrison and Cyndi O’Meara join Chadi to explore vitalistic principles that emphasize natural health approaches without relying on medication. They dive into how the holiday season amplifies mental health and nutritional struggles and share actionable strategies to tackle these challenges beyond mere willpower. With an anthropological lens, they break down how understanding your unique body can guide you to maintain a healthy weight, improve overall health, and develop lasting habits. The conversation also provides practical tips for identifying high-quality ingredients and making mindful food choices that support your wellness goals.
Check out Chadi’s website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/
Watch all Healthcare Unfiltered episodes on YouTube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA
N/A
Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous
Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those
Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease
